News Release

View printer-friendly version
<< Back

DURECT Corporation Presenting at the Halpern Capital Summer Growth Stock Conference

CUPERTINO, Calif., Aug. 9 /PRNewswire-FirstCall/ -- DURECT Corporation (Nasdaq: DRRX) announced today that it will present at the Halpern Capital Summer Growth Stock Conference. The conference is being held at The Campton Place Hotel in San Francisco, CA. Dr. Felix Theeuwes, Chairman and Chief Scientific Officer, will be presenting at the conference on Tuesday, August 10, 2004 at 8:20 a.m. Pacific Time.

(Logo: )

A live audio webcast of the presentation will be available by accessing DURECT's homepage at and clicking "Investor Relations".

DURECT Corporation ( is pioneering the development and commercialization of pharmaceutical systems for the treatment of chronic debilitating diseases and enabling biotechnology-based pharmaceutical products. DURECT's goal is to deliver the right drug to the right site in the right amount at the right time.


/CONTACT: Schond L. Greenway, Executive Director, Investor Relations and
Strategic Planning of DURECT Corporation, +1-408-777-1417/
/Photo: NewsCom:
AP Archive:
PRN Photo Desk, +1-888-776-6555 or +1-212-782-2840/
/Web site: